Indicator,S.No.,Parameters,Type,District - _Delhi,District - Central,District - East,District - New Delhi,District - North,District - North East,District - North West,District - Shahdara,District - South,District - South East,District - South West,District - West
M1 [Ante Natal Care Services ANC],1.1,Total number of pregnant women Registered for ANC,TOTAL,79262,10023,4279,7648,7647,5326,9191,10230,3544,3900,3504,13970
M1 [Ante Natal Care Services ANC],1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,29527,4144,1242,1703,2073,1997,3836,3135,1412,1783,1801,6401
M1 [Ante Natal Care Services ANC],1.2,Number of Pregnant women registered under JSY,TOTAL,2681,383,77,149,139,106,301,635,50,206,206,429
M1 [Ante Natal Care Services ANC],1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,43315,6383,1707,4375,3549,3243,6099,4344,1954,1766,2085,7810
M1 [Ante Natal Care Services ANC],1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,27683,2823,1512,3706,2392,1986,3446,2872,1437,1917,1769,3823
M1 [Ante Natal Care Services ANC],1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,20430,2391,1303,1595,2078,1594,2695,1477,1192,1702,1549,2854
M1 [Ante Natal Care Services ANC],1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,42273,4861,1503,4398,4167,2560,5363,3792,1732,1949,2160,9788
M1 [Ante Natal Care Services ANC],1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,1797,105,36,161,85,71,368,86,163,31,211,480
M1 [Ante Natal Care Services ANC],1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,57,17,1,16,6,1,3,0,1,2,1,9
M1 [Ante Natal Care Services ANC],1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,27013,2295,1252,3504,2275,1821,6388,2282,737,1771,1972,2716
M1 [Ante Natal Care Services ANC],1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1180,75,58,142,113,28,197,103,27,30,179,228
M1 [Ante Natal Care Services ANC],1.8,Number of pregnancy test kits used at SC level,TOTAL,1962,81,88,231,105,134,108,82,574,440,23,96
M2 [Deliveries],2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,82,0,8,0,0,0,2,0,42,30,0,0
M2 [Deliveries],2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1161,87,41,36,248,205,111,48,89,87,61,148
M2 [Deliveries],2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1243,87,49,36,248,205,113,48,131,117,61,148
M2 [Deliveries],2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,661,68,30,26,140,94,26,37,42,57,35,106
M2 [Deliveries],2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,7,2,0,2,0,0,1,0,0,0,2,0
M2 [Deliveries],2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,14693,2360,587,3081,496,512,2351,2316,365,293,668,1664
M2 [Deliveries],2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,6921,1082,288,2147,196,438,564,364,233,175,447,987
M2 [Deliveries],2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,857,143,29,59,77,3,224,107,22,18,139,36
M2 [Deliveries],2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,256,42,31,28,1,1,5,9,21,8,99,11
M2 [Deliveries],2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M2 [Deliveries],2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,3248,678,239,16,60,19,556,244,401,392,156,487
M2 [Deliveries],2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,NA
M2 [Deliveries],2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,NA
M2 [Deliveries],2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,NA,0,0,NA,0,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2,0,NA,2,NA,0,0,NA,NA,0,NA,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3310,641,151,761,43,80,549,341,120,32,123,469
M3 [Number of Caesarean C-Section deliveries performed at],3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3312,641,151,763,43,80,549,341,120,32,123,469
M3 [Number of Caesarean C-Section deliveries performed at],3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1892,410,152,7,15,16,355,143,195,202,93,304
M4 [Pregnancy outcome & weight of new-born],4.1.1.a,Number of male live births,TOTAL,9941,1641,456,1621,416,371,1510,1384,491,415,469,1167
M4 [Pregnancy outcome & weight of new-born],4.1.1.b,Number of female live births,TOTAL,9156,1492,407,1485,383,358,1484,1222,416,400,414,1095
M4 [Pregnancy outcome & weight of new-born],4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,19097,3133,863,3106,799,729,2994,2606,907,815,883,2262
M4 [Pregnancy outcome & weight of new-born],4.1.2,Number of still births,TOTAL,293,58,17,76,9,7,60,6,7,6,4,43
M4 [Pregnancy outcome & weight of new-born],4.1.3,Number of Abortions (spontaneous or induced),TOTAL,3455,610,405,286,156,61,482,328,254,230,158,485
M4 [Pregnancy outcome & weight of new-born],4.2.1,Number of Newborns weighed at birth,TOTAL,18407,3091,847,3083,727,640,2917,2593,843,707,870,2089
M4 [Pregnancy outcome & weight of new-born],4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,3607,691,163,383,99,93,556,794,119,75,131,503
M4 [Pregnancy outcome & weight of new-born],4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,14132,2073,480,2517,707,573,2418,2085,657,450,689,1483
M5 [Complicated pregnanices],5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,NA,0,0,NA,NA,0,0,0,0,0,0
M5 [Complicated pregnanices],5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,31,0,6,0,NA,0,0,12,NA,13,NA,0
M5 [Complicated pregnanices],5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5239,1338,279,662,631,38,812,420,391,50,58,560
M5 [Complicated pregnanices],5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M5 [Complicated pregnanices],5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,5270,1338,285,662,631,38,812,432,391,63,58,560
M5 [Complicated pregnanices],5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,552,125,13,0,4,14,74,99,137,70,11,5
M5 [Complicated pregnanices],5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,3857,1027,291,499,113,49,493,460,259,119,19,528
M5 [Complicated pregnanices],5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,372,37,2,88,12,16,30,34,20,12,6,115
M5 [Complicated pregnanices],5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,3599,1311,169,257,126,46,709,180,336,121,19,325
M5 [Complicated pregnanices],5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1294,118,206,234,37,6,289,39,25,17,28,295
M6 [Post - Natal Care],6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,16378,2831,642,3113,712,655,2811,1321,828,708,795,1962
M6 [Post - Natal Care],6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,12352,1625,467,1046,793,581,2531,623,455,765,1201,2265
M6 [Post - Natal Care],6.3,PNC maternal complications attended,TOTAL,569,29,171,65,37,0,139,2,20,21,17,68
M7 [Medical Termination of Pregnancy (MTP)],7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,573,122,9,85,22,8,90,62,54,13,22,86
M7 [Medical Termination of Pregnancy (MTP)],7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,75,11,4,27,1,0,5,6,16,0,0,5
M7 [Medical Termination of Pregnancy (MTP)],7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,648,133,13,112,23,8,95,68,70,13,22,91
M7 [Medical Termination of Pregnancy (MTP)],7.2,Number of MTPs conducted at Private Facilities,TOTAL,1221,168,296,10,32,5,152,90,95,151,57,165
M8 [RTI/STI Cases],8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2750,455,147,461,151,87,226,105,206,267,223,422
M8 [RTI/STI Cases],8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,14597,1756,956,2172,958,1087,1248,948,587,842,858,3185
M8 [RTI/STI Cases],8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,17347,2211,1103,2633,1109,1174,1474,1053,793,1109,1081,3607
M8 [RTI/STI Cases],8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,32,0,1,0,NA,0,0,0,0,3,0,28
M9 [Family Planning],9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,NA,0,0,0,0,0,NA,0
M9 [Family Planning],9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,NA,NA,0
M9 [Family Planning],9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,90,62,0,8,0,NA,4,6,3,0,2,5
M9 [Family Planning],9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,90,62,0,8,0,0,4,6,3,0,2,5
M9 [Family Planning],9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2,2,0,0,NA,NA,0,0,0,0,0,NA
M9 [Family Planning],9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,NA,NA,0,0,0,0,NA,0
M9 [Family Planning],9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,NA,NA,0
M9 [Family Planning],9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,484,140,1,82,9,0,66,46,44,7,24,65
M9 [Family Planning],9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,484,140,1,82,9,0,66,46,44,7,24,65
M9 [Family Planning],9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,186,8,4,5,1,NA,91,53,0,12,0,12
M9 [Family Planning],9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0,0,0,0,NA,NA,0,0,0,0,NA,0
M9 [Family Planning],9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,NA,NA,0
M9 [Family Planning],9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,130,13,13,65,3,0,7,12,5,0,2,10
M9 [Family Planning],9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,130,13,13,65,3,0,7,12,5,0,2,10
M9 [Family Planning],9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,7,1,1,0,NA,NA,0,0,1,2,0,2
M9 [Family Planning],9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,NA,NA,0,0,0,0,NA,0
M9 [Family Planning],9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,NA,NA,NA,0,0,NA,NA,NA,NA,0
M9 [Family Planning],9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,338,28,0,40,3,4,119,72,9,2,8,53
M9 [Family Planning],9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,338,28,0,40,3,4,119,72,9,2,8,53
M9 [Family Planning],9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,27,9,0,0,1,NA,2,0,0,7,0,8
M9 [Family Planning],9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0,0,0,0,NA,0,0,0,NA,NA,0,0
M9 [Family Planning],9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1576,222,106,60,109,117,166,106,149,145,169,227
M9 [Family Planning],9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,550,70,45,30,53,91,57,27,NA,75,11,91
M9 [Family Planning],9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4141,674,309,688,226,121,744,425,139,63,133,619
M9 [Family Planning],9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,6267,966,460,778,388,329,967,558,288,283,313,937
M9 [Family Planning],9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3501,533,296,577,229,138,666,341,73,63,84,501
M9 [Family Planning],9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,319,41,23,13,22,4,50,33,16,45,23,49
M9 [Family Planning],9.06,Number of IUCD removals,TOTAL,1173,153,73,120,88,79,113,110,82,72,109,174
M9 [Family Planning],9.07,Number of Oral Pills cycles distributed,TOTAL,13238,1622,1084,996,1266,673,1479,1230,858,1386,996,1648
M9 [Family Planning],9.08,Number of Condom pieces distributed,TOTAL,561623,62658,20591,38786,50983,39250,80455,33753,56326,64952,46630,67239
M9 [Family Planning],9.09,Number of Centchroman (weekly) pills given,TOTAL,11,0,0,0,0,0,0,0,4,0,0,7
M9 [Family Planning],9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,1140,81,113,45,128,64,182,124,125,115,24,139
M9 [Family Planning],9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M9 [Family Planning],9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M9 [Family Planning],9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M9 [Family Planning],9.11.2.b,Number of failures following female sterilization,TOTAL,3,1,0,1,NA,0,1,0,0,0,0,0
M9 [Family Planning],9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M9 [Family Planning],9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M9 [Family Planning],9.12,Number of Institutions having NSV trained doctors,TOTAL,52,5,3,6,4,NA,12,8,3,4,3,4
M10 [CHILD IMMUNIZATION],10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,22256,3113,1143,3204,1303,1195,3364,2873,1003,1263,1094,2701
M10 [CHILD IMMUNIZATION],10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1458,228,74,13,65,58,234,78,135,275,45,253
M10 [CHILD IMMUNIZATION],10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1301,194,69,17,61,48,168,58,159,227,54,246
M10 [CHILD IMMUNIZATION],10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1322,196,62,16,69,70,185,64,144,229,65,222
M10 [CHILD IMMUNIZATION],10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,23779,2432,1511,1342,2160,2437,3093,2195,1329,2241,1849,3190
M10 [CHILD IMMUNIZATION],10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,24214,2265,1769,1290,2250,2365,3198,2076,1541,2248,1893,3319
M10 [CHILD IMMUNIZATION],10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,23380,2233,1526,1171,2203,2327,3081,2083,1412,2196,1867,3281
M10 [CHILD IMMUNIZATION],10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,16668,2625,843,2820,605,637,2444,2434,750,600,827,2083
M10 [CHILD IMMUNIZATION],10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,24202,2616,1629,1217,2190,2388,3066,2303,1217,2323,1880,3373
M10 [CHILD IMMUNIZATION],10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,24528,2433,1875,1200,2278,2325,3091,2116,1471,2293,1940,3506
M10 [CHILD IMMUNIZATION],10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,23825,2416,1618,1114,2220,2278,3040,2064,1402,2277,1931,3465
M10 [CHILD IMMUNIZATION],10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,16242,2460,819,2753,660,543,2648,2504,714,587,793,1761
M10 [CHILD IMMUNIZATION],10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1380,323,111,16,11,4,186,62,143,176,45,303
M10 [CHILD IMMUNIZATION],10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1089,193,58,10,17,15,197,62,139,184,49,165
M10 [CHILD IMMUNIZATION],10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1064,226,42,16,26,26,155,67,128,156,84,138
M10 [CHILD IMMUNIZATION],10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,23817,2277,1640,1225,2386,2295,2982,1984,1526,2481,1870,3151
M10 [CHILD IMMUNIZATION],10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2371,371,177,75,171,352,284,124,260,292,77,188
M10 [CHILD IMMUNIZATION],10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,12331,1156,834,646,1259,1157,1502,1036,779,1255,1053,1654
M10 [CHILD IMMUNIZATION],10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,10635,1022,772,540,1063,1046,1402,890,678,1036,795,1391
M10 [CHILD IMMUNIZATION],10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,22966,2178,1606,1186,2322,2203,2904,1926,1457,2291,1848,3045
M10 [CHILD IMMUNIZATION],10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,28132,2521,2095,1414,2683,2636,3592,2397,1797,2449,2325,4223
M10 [CHILD IMMUNIZATION],10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,27460,2497,2077,1409,2702,2630,3530,2196,1792,2312,2321,3994
M10 [CHILD IMMUNIZATION],10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,31244,2713,2235,1829,3083,2505,4135,2929,1993,2985,2511,4326
M10 [CHILD IMMUNIZATION],10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4388,541,81,362,603,532,474,425,249,161,266,694
M10 [CHILD IMMUNIZATION],10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3674,455,86,288,417,464,433,368,216,160,215,572
M10 [CHILD IMMUNIZATION],10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,8062,996,167,650,1020,996,907,793,465,321,481,1266
M10 [CHILD IMMUNIZATION],10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,10405,1174,632,700,917,626,1249,793,764,1102,893,1555
M10 [CHILD IMMUNIZATION],10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,3347,423,239,273,192,373,351,249,300,363,234,350
M10 [CHILD IMMUNIZATION],10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2395,405,154,179,168,169,276,255,195,172,250,172
M10 [CHILD IMMUNIZATION],10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,1,0,0,NA,0,1,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,9326,1232,737,516,981,661,1235,588,567,914,567,1328
M10 [CHILD IMMUNIZATION],10.4.2,Number of Immunisation sessions held during the month,TOTAL,8984,1180,713,475,916,652,1191,570,562,890,543,1292
M10 [CHILD IMMUNIZATION],10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4866,241,456,221,504,530,630,299,265,575,411,734
M10 [CHILD IMMUNIZATION],10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M11 [Number of Vitamin A doses],11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,12577,134,1417,263,695,1216,903,1355,1315,1039,1605,2635
M11 [Number of Vitamin A doses],11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,9996,78,1515,66,1448,773,540,936,858,735,748,2299
M11 [Number of Vitamin A doses],11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3718,44,581,50,295,486,248,245,403,294,435,637
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,2,0,0,2,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,215,17,28,19,20,8,8,56,37,11,0,11
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,7619,706,821,1171,292,168,850,557,346,654,178,1876
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,70,8,4,8,40,0,5,0,2,0,2,1
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1708,125,199,533,91,0,203,77,118,74,22,266
M13 [Blindness Control Programme],13.1,Number of Patients operated for cataract,TOTAL,6081,3099,111,665,47,49,550,249,88,375,1,847
M13 [Blindness Control Programme],13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,5756,3034,59,659,27,49,447,173,87,374,1,846
M13 [Blindness Control Programme],13.3,Number of School children detected with Refractive errors,TOTAL,2048,91,0,0,145,130,287,218,262,95,92,728
M13 [Blindness Control Programme],13.4,Number of children provided free glasses,TOTAL,232,0,0,0,0,0,75,0,0,0,0,157
M13 [Blindness Control Programme],13.5,Number of eyes collected through eye donation,TOTAL,57,27,0,6,0,0,0,0,0,0,0,24
M13 [Blindness Control Programme],13.6,Number of eyes utilised for corneal transplant,TOTAL,43,17,0,2,0,0,0,0,0,0,0,24
M14 [Patient Services],14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,37,5,2,4,3,4,8,6,NA,NA,1,4
M14 [Patient Services],14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,233,5,3,0,0,0,138,0,28,42,6,11
M14 [Patient Services],14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,35,4,4,1,3,4,6,6,NA,1,2,4
M14 [Patient Services],14.05,Number of RKS meetings held during the month,TOTAL,4,0,0,0,0,1,1,0,0,1,0,1
M14 [Patient Services],14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,192,14,40,27,6,4,20,11,12,15,32,11
M14 [Patient Services],14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,4389,230,582,1269,63,152,465,306,161,270,206,685
M14 [Patient Services],14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,62,9,7,3,3,1,9,7,12,5,1,5
M14 [Patient Services],14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,166,30,16,30,2,0,47,7,7,12,2,13
M14 [Patient Services],14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,21677,4157,1634,4948,688,328,3865,1892,612,1136,751,1666
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,46525,13812,2509,7153,518,296,6857,4628,1616,3600,1284,4252
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,15822,2727,1042,3521,503,275,3092,1451,462,816,660,1273
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,63085,14483,3985,9552,1328,821,10173,7851,2347,3104,2229,7212
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,37499,6884,2676,8469,1191,603,6957,3343,1074,1952,1411,2939
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,109610,28295,6494,16705,1846,1117,17030,12479,3963,6704,3513,11464
M14 [Patient Services],14.10.2.a,Number of death cases of Inpatient males,TOTAL,1855,685,161,337,40,2,277,93,31,29,14,186
M14 [Patient Services],14.10.2.b,Number of death cases of Inpatient females,TOTAL,1153,340,107,265,13,2,199,64,29,18,9,107
M14 [Patient Services],14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3008,1025,268,602,53,4,476,157,60,47,23,293
M14 [Patient Services],14.11,In-Patient Head Count at midnight,TOTAL,354071,38324,29758,102825,11056,2521,52889,25899,15561,31147,5072,39019
M14 [Patient Services],14.12.1,OPD attendance (All),TOTAL,4894549,703452,279352,781753,277586,247545,640143,508408,200108,293004,321576,641622
M14 [Patient Services],14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,26998,6158,1983,4989,363,191,3410,1473,1767,2956,521,3187
M14 [Patient Services],14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,651,75,69,64,38,4,117,29,49,148,15,43
M14 [Patient Services],14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,48663,4173,3115,7741,2991,962,5709,2157,578,2109,509,18619
M14 [Patient Services],14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.14.a,Number of patients given AYUSH treatment,TOTAL,149492,30740,16194,19522,15510,894,17988,21324,1326,3769,7028,15197
M14 [Patient Services],14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,45058,10981,1274,10903,2395,247,3450,1620,1397,3066,2569,7156
M14 [Patient Services],14.14.c,Number of Adolescents counselled,TOTAL,5877,1423,384,469,729,327,859,242,42,272,602,528
M15 [Laboratory Testing],15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,241523,241523,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M15 [Laboratory Testing],15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,445968,159458,24978,53910,10946,6584,48070,35136,29353,15505,20129,41899
M15 [Laboratory Testing],15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,10985,1541,692,875,380,352,1508,1472,312,238,431,3184
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,1. Number tested,23203,4766,2523,3335,820,591,3391,1799,2422,550,741,2265
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,373,25,23,134,12,14,73,35,10,8,7,32
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,15552,2077,1279,2389,862,748,2720,1185,1336,760,506,1690
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,117,7,8,47,5,2,22,2,6,0,0,18
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,25272,3883,1784,2538,2262,1962,3579,2217,1245,1202,2216,2384
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,55,5,3,5,1,0,3,2,1,0,1,34
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,64027,10726,5586,8262,3944,3301,9690,5201,5003,2512,3463,6339
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,545,37,34,186,18,16,98,39,17,8,8,84
M15 [Laboratory Testing],15.2,Number of Widal tests conducted,Number tested,17449,1880,1368,1801,1421,514,2402,1906,1235,991,1319,2612
M15 [Laboratory Testing],15.3.a,Number of VDRL tests conducted on males,Number tested,5281,675,1223,1416,146,23,306,373,388,275,96,360
M15 [Laboratory Testing],15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,5088,462,305,1863,270,125,373,154,188,109,174,1065
M15 [Laboratory Testing],15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,23201,1926,1519,2929,1758,1562,4474,2110,1010,921,2658,2334
M15 [Laboratory Testing],15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,33570,3063,3047,6208,2174,1710,5153,2637,1586,1305,2928,3759
M15 [Laboratory Testing],15.4.1,Number of blood smears examined for Malaria,TOTAL,49552,1905,1512,1633,508,300,2854,1814,34257,878,1487,2404
M15 [Laboratory Testing],15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,26,1,3,4,2,1,1,3,1,2,5,3
M15 [Laboratory Testing],15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3,2,0,0,0,0,0,0,1,0,0,0
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,28020,380,4530,2800,1530,2980,640,1130,3680,4180,4540,1630
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,2. Stocks Received,21520,3500,0,0,2520,3000,2500,2000,1000,2000,1500,3500
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,3. Unusable Stock,3000,NA,0,0,0,0,3000,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,4. Stock Distributed,18920,1550,2920,640,950,2680,140,2150,1350,2430,2150,1960
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,5. Total Stock,27620,2330,1610,2160,3100,3300,0,980,3330,3750,3890,3170
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,33890,890,2090,3810,630,7330,400,2120,4260,4910,5020,2430
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,2. Stocks Received,36720,4800,2160,0,3840,2400,5520,4320,1200,4800,1920,5760
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,2570,NA,0,0,0,0,2570,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,34490,2940,2640,1160,1610,5240,3350,3840,1870,3640,3750,4450
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,5. Total Stock,33550,2750,1610,2650,2860,4490,0,2600,3590,6070,3190,3740
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,43910,24500,80,240,590,NA,420,480,3040,680,7740,6140
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,2. Stocks Received,56120,16000,28040,800,0,NA,80,700,3000,3000,0,4500
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,NA,0,0,0,NA,NA,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,4. Stock Distributed,70910,26640,17600,1040,590,NA,500,1180,4300,680,7740,10640
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,5. Total Stock,29120,13860,10520,0,0,0,0,0,1740,3000,0,0
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,25820,490,2100,4530,970,3620,1360,860,2600,3290,4270,1730
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,2. Stocks Received,28060,3500,3060,0,3500,3000,4500,2000,1500,2000,2000,3000
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,3. Unusable Stock,3230,NA,0,0,0,0,3230,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,4. Stock Distributed,23620,2160,2540,1180,1320,3100,2630,1790,1260,2260,3700,1680
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,5. Total Stock,27030,1830,2620,3350,3150,3520,0,1070,2840,3030,2570,3050
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,26770,540,3060,2740,1830,3680,2470,1180,4660,4170,2240,200
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,2. Stocks Received,11000,1000,0,0,1500,1000,2500,1500,0,1000,500,2000
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,3. Unusable Stock,4190,NA,NA,0,0,0,4190,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,4. Stock Distributed,14480,1030,1110,430,950,2240,780,1700,1830,1540,670,2200
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,5. Total Stock,19100,510,1950,2310,2380,2440,0,980,2830,3630,2070,0
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,26940,535,1830,3695,850,4270,1560,1970,3090,3505,5135,500
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,2. Stocks Received,20000,3000,1500,0,3500,2000,3000,1500,1500,1000,1000,2000
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,3. Unusable Stock,2975,NA,0,0,0,0,2975,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,4. Stock Distributed,18460,2285,1450,530,1990,2480,1585,1450,1345,2050,1545,1750
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,5. Total Stock,25505,1250,1880,3165,2360,3790,0,2020,3245,2455,4590,750
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,NA,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,2. Stocks Received,0,NA,NA,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,NA,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,NA,NA,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,13030,400,2870,770,270,810,850,680,1750,1780,1490,1360
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,500,NA,0,0,0,0,NA,0,0,0,0,500
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,680,NA,0,0,0,0,680,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2710,390,270,120,0,310,170,50,230,230,130,810
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,10140,10,2600,650,270,500,0,630,1520,1550,1360,1050
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3780,84,71,143,257,388,275,100,462,565,1010,425
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,1400,NA,600,0,0,0,NA,0,0,600,0,200
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,275,NA,0,0,0,0,275,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1514,NA,70,30,244,200,NA,0,50,350,20,550
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3391,84,601,113,13,188,0,100,412,815,990,75
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,197030,1920,5500,10500,9540,28800,120000,1800,NA,NA,18970,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,369900,32400,0,0,35100,32400,259200,10800,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,349200,NA,0,0,0,0,349200,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,140120,25600,5500,5500,16720,30000,30000,10800,NA,NA,16000,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,77610,8720,0,5000,27920,31200,0,1800,0,0,2970,0
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,16180,150,550,1610,1135,2070,2515,600,2000,2000,3495,55
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,7500,1500,2000,0,0,1000,NA,0,0,1000,0,2000
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,1802,NA,0,0,0,NA,1802,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,7681,1089,979,340,380,300,713,600,700,700,620,1260
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,14197,561,1571,1270,755,2770,0,0,1300,2300,2875,795
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6470,190,0,85,445,955,3320,500,NA,NA,725,250
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,NA,0,0,0,0,NA,0,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,2620,NA,0,0,0,0,2620,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,1583,130,0,10,445,10,700,150,NA,NA,40,98
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2267,60,0,75,0,945,0,350,0,0,685,152
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,664,NA,0,NA,NA,0,664,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,664,NA,0,NA,NA,0,664,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,NA,NA,NA,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,2. Stocks Received,10000,NA,0,NA,NA,0,10000,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,10000,NA,0,NA,NA,0,10000,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,NA,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,858,NA,360,3,1,0,29,78,76,8,244,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,110,NA,0,0,0,0,10,0,0,100,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,13,NA,0,0,0,0,13,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,549,NA,137,3,1,0,26,78,62,68,115,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,5. Total Stock,406,0,223,0,0,0,0,0,14,40,129,0
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,10910,NA,0,1850,NA,0,NA,5500,NA,NA,3560,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,NA,0,0,NA,0,NA,0,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,NA,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,3450,NA,0,450,NA,0,NA,1900,NA,NA,1100,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,7460,0,0,1400,0,0,0,3600,0,0,2460,0
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,26495,3400,866,1160,2000,4692,400,1200,2400,3400,3557,3420
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2800,NA,0,0,0,0,NA,2000,0,0,0,800
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,200,NA,0,0,0,0,200,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5015,600,260,305,800,400,200,0,800,0,280,1370
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,24080,2800,606,855,1200,4292,0,3200,1600,3400,3277,2850
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,205220,9800,4600,18000,3820,24000,3300,2600,52000,52600,34500,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,96400,7600,10800,0,14400,18000,15200,14400,0,0,0,16000
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,6500,NA,0,0,0,0,6500,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,129290,13100,10600,4600,8100,20300,12000,12500,6600,14100,13800,13590
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,165830,4300,4800,13400,10120,21700,0,4500,45400,38500,20700,2410
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,25603,400,70,1065,2500,1995,200,0,4800,10000,3208,1365
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,9000,NA,2000,0,0,2000,2500,2000,0,0,0,500
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,2100,NA,0,0,0,0,2100,NA,NA,0,0,NA
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,6585,300,270,250,1100,600,600,500,400,500,1270,795
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,25918,100,1800,815,1400,3395,0,1500,4400,9500,1938,1070
M17 [Details of deaths reported during the month with probable causes:],17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,5,1,NA,NA,2,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,42,3,16,17,NA,NA,6,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,4,2,NA,2,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,46,5,16,19,NA,NA,6,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,36,2,16,10,2,NA,6,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,36,2,16,10,2,NA,6,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,33,5,NA,7,NA,NA,3,NA,NA,NA,1,17
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,33,5,NA,7,NA,NA,3,NA,NA,NA,1,17
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,45,1,8,12,1,NA,13,1,NA,NA,2,7
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,6,1,1,1,1,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,51,2,9,13,2,NA,15,1,NA,NA,2,7
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,19,NA,7,8,2,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,8,NA,3,4,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,27,NA,10,12,2,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,4,NA,NA,3,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,4,NA,NA,3,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,6,NA,NA,5,NA,1,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,2,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,8,NA,NA,7,NA,1,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,53,4,12,25,2,NA,5,4,1,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,17,1,2,6,1,NA,4,1,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,70,5,14,31,3,NA,9,5,1,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,12,5,1,3,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,5,NA,1,NA,NA,NA,4,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,17,5,2,3,NA,NA,6,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,3,NA,NA,1,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,40,1,3,12,NA,NA,18,NA,1,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,29,3,NA,14,NA,NA,6,1,NA,NA,1,4
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,72,4,3,27,NA,NA,25,1,1,NA,1,10
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,5,NA,NA,3,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,66,7,9,14,3,NA,14,3,NA,2,4,10
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,99,12,15,10,3,NA,27,6,1,2,6,17
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,170,19,24,27,7,NA,41,9,1,4,10,28
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,5,NA,NA,3,1,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,8,2,NA,NA,1,NA,4,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,15,1,1,2,NA,NA,8,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,28,3,1,5,2,NA,13,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,8,NA,NA,1,NA,NA,3,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,9,NA,NA,1,NA,NA,4,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,82,6,6,18,2,NA,20,6,NA,2,5,17
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,176,27,13,38,2,NA,39,9,11,6,1,30
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,259,33,19,56,4,NA,60,15,11,8,6,47
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,4,NA,NA,2,NA,NA,2,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,35,6,4,6,2,NA,9,4,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,39,3,5,5,NA,NA,19,3,1,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,78,9,9,13,2,NA,30,7,1,NA,1,6
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,2,NA,NA,1,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,2,NA,NA,1,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,3,NA,NA,2,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,3,NA,NA,2,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,3,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,3,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,8,NA,NA,6,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,8,NA,NA,6,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,3,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,61,4,3,21,18,NA,9,NA,NA,NA,1,5
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,21,2,4,5,3,NA,2,NA,NA,NA,1,4
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,85,6,7,28,21,NA,11,NA,NA,NA,2,10
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9,NA,NA,NA,2,NA,5,NA,NA,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2,NA,1,NA,NA,NA,NA,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,11,NA,1,NA,2,NA,5,NA,NA,NA,2,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,13,1,8,4,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,135,18,3,92,1,NA,14,1,NA,NA,NA,6
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,107,19,NA,70,NA,NA,13,NA,NA,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,255,38,11,166,1,NA,27,1,NA,NA,NA,11
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,7,NA,2,5,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,123,24,10,42,1,NA,18,NA,NA,NA,2,26
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,150,40,14,40,1,NA,29,3,NA,NA,4,19
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,280,64,26,87,2,NA,47,3,NA,NA,6,45
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,93,3,30,17,5,NA,35,NA,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,36,1,7,7,NA,NA,17,NA,NA,NA,4,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,131,4,39,24,5,NA,52,NA,NA,NA,4,3
